Tizona Therapeutics

Biotechnology company that developed immuno-oncology therapeutics targeting immune checkpoints to enhance anti-tumor immune responses. Acquired by Arcus Biosciences.

Location
South San Francisco, California, USA
Founded
2014
Investors
1
Categories
biotech, immunotherapy, oncology, acquired

Investors

NameLocationTypeStagesPortfolio
AbingworthLondon, UK / Boston, USAbiotech-focused
seedseries-a+3
34